TCG Crossover Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839948

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2025 · 40 positions · Total reported value $2.03B · Top-10 concentration 65.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 44.3% · 7 new · 15 cut · 5 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.6% · vs SPY -9.8% · Prev Value $4.16B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.9% · vs SPY -5.0% · Latest Value $3.54B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, TCG Crossover Management, LLC disclosed 40 equity positions with a combined reported value of $2.03B. The filing implies a focused portfolio: its ten largest positions account for 65.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were ABVX ($603.77M), CGON ($147.84M), COGT ($97.62M). By sector, the heaviest allocations are Health Care 87.2%, Industrials 2.5%. Versus the prior quarter, allocation shifted toward Health Care (+10.3pp) and away from Industrials (-1.3pp), Other (-9.0pp).

Versus the prior quarter, TCG Crossover Management, LLC opened 7 new positions, trimmed 15 and fully exited 5, a turnover rate of 44.3% of positions. The portfolio's overlap with the prior quarter was 60% of names.

The largest new positions opened in Q3 2025 were LQDA ($38.89M), LBRX ($27.55M), RVMD ($20.38M).

Of the 5 positions fully exited versus the prior quarter, the largest were CDTX ($49.00M), SLNO ($15.60M), THRD ($10.40M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • LQDA LIQUIDIA CORPORATION · $38.89M
  • LBRX LB PHARMACEUTICALS INC · $27.55M
  • RVMD REVOLUTION MEDICINES INC · $20.38M
  • KRRO KORRO BIO INC · $19.94M
  • SYRE SPYRE THERAPEUTICS INC · $18.45M
  • URGN UROGEN PHARMA LTD · $14.31M
  • ARVN ARVINAS INC · $13.78M
  • MNPR MONOPAR THERAPEUTICS INC · $12.50M

Fully Exited (vs previous quarter)

  • CDTX CIDARA THERAPEUTICS INC · prev qtr: $49.00M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $15.60M
  • THRD THIRD HARMONIC BIO INC · prev qtr: $10.40M
  • ELVN ENLIVEN THERAPEUTICS INC · prev qtr: $9.99M
  • NKTR NEKTAR THERAPEUTICS · prev qtr: $6.89M
  • KURA KURA ONCOLOGY INC · prev qtr: $4.24M
  • JBIO JADE BIOSCIENCES INC · prev qtr: $639.59K
  • CABA CABALETTA BIO INC · prev qtr: $131.93K

Insider Transactions (Form 4)

Latest TCG Crossover Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

TCG Crossover Management, LLC, based in Palo Alto, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 54 positions worth $4.16B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: PALO ALTO, CA, United States
  • SEC registration: 801-120001 (status: Approved), registered 2020-12-18
  • Regulatory AUM (Form ADV): $5.06B as of 2026-05-29
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds
  • Website: tcgcrossover.com

Portfolio Structure

  • 54 positions · $4.16B reported value (Q2 2026)
  • Top 10 holdings = 57.4% of reported value
  • Largest position: ABVX (ABIVAX SA) at 19.2%
  • Average position size: $77.05M

Sector Tilt

  • Health Care 99.3%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 12 new, 2 added, 9 reduced, 7 exited
  • 31 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 87.2%
Other 10.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 7.11M $603.77M 29.70%
29.70%
Add
2 3.67M $147.84M 7.27%
7.27%
Hold
3 6.80M $97.62M 4.80%
4.80%
Reduce
4 6.24M $84.85M 4.17%
4.17%
Add
5 3.14M $76.06M 3.74%
3.74%
Add
6 8.54M $71.70M 3.53%
3.53%
Reduce
7 6.12M $71.51M 3.52%
3.52%
Add
8 1.68M $65.98M 3.25%
3.25%
Add
9 1.31M $62.74M 3.09%
3.09%
Reduce
10 4.62M $58.38M 2.87%
2.87%
Add
11 1.43M $57.40M 2.82%
2.82%
Add
12 3.57M $50.87M 2.50%
2.50%
Hold
13 5.25M $48.30M 2.38%
2.38%
Hold
14 12.36M $44.13M 2.17%
2.17%
Hold
15 1.64M $42.20M 2.08%
2.08%
Hold
16 2.90M $40.54M 1.99%
1.99%
Hold
17 2.12M $39.82M 1.96%
1.96%
Reduce
18 1.71M $38.89M 1.91%
1.91%
New
19 465.26K $30.74M 1.51%
1.51%
Hold
20 1.06M $29.76M 1.46%
1.46%
Hold
21 2.45M $28.76M 1.42%
1.42%
Hold
22 1.75M $27.55M 1.35%
1.35%
New
23 436.47K $20.38M 1.00%
1.00%
New
24 2.76M $20.11M 0.99%
0.99%
Hold
25 416.30K $19.94M 0.98%
0.98%
New
26 1.15M $18.75M 0.92%
0.92%
Hold
27 1.10M $18.45M 0.91%
0.91%
New
28 3.03M $15.74M 0.77%
0.77%
Hold
29 717.35K $14.31M 0.70%
0.70%
New
30 1.62M $13.78M 0.68%
0.68%
New
31 153.00K $12.50M 0.61%
0.61%
New
32 650.00K $11.38M 0.56%
0.56%
Hold
33 2.68M $9.50M 0.47%
0.47%
Hold
34 1.81M $9.45M 0.47%
0.47%
New
35 1.67M $7.56M 0.37%
0.37%
Reduce
36 483.00K $6.14M 0.30%
0.30%
Hold
37 1.39M $5.56M 0.27%
0.27%
New
38 1.20M $5.54M 0.27%
0.27%
New
39 584.96K $3.39M 0.17%
0.17%
Hold
40 316.19K $983.37K 0.05%
0.05%
Hold

FAQ

What did TCG Crossover Management, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, TCG Crossover Management, LLC reported 40 equity positions worth $2.03B in aggregate; its largest disclosed positions were ABVX ($603.77M), CGON ($147.84M), COGT ($97.62M).

How large is TCG Crossover Management, LLC's portfolio?

TCG Crossover Management, LLC reported $2.03B of long equity holdings across 40 positions as of 2025-Q3. Top-10 holdings account for 65.9% of reported value.

What is TCG Crossover Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tcg-crossover-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →